nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—Phensuximide—Primidone—epilepsy syndrome	0.12	0.253	CrCrCtD
Menadione—Phensuximide—Clobazam—epilepsy syndrome	0.0672	0.141	CrCrCtD
Menadione—Phenindione—Fosphenytoin—epilepsy syndrome	0.0651	0.137	CrCrCtD
Menadione—Phensuximide—Diazepam—epilepsy syndrome	0.0625	0.131	CrCrCtD
Menadione—AOX1—Zonisamide—epilepsy syndrome	0.0543	0.15	CbGbCtD
Menadione—Phenindione—Phenytoin—epilepsy syndrome	0.0446	0.0939	CrCrCtD
Menadione—MAOB—Zonisamide—epilepsy syndrome	0.0432	0.119	CbGbCtD
Menadione—Phenindione—Carbamazepine—epilepsy syndrome	0.0412	0.0867	CrCrCtD
Menadione—Phenindione—Oxcarbazepine—epilepsy syndrome	0.0379	0.0798	CrCrCtD
Menadione—Phenindione—Clobazam—epilepsy syndrome	0.0364	0.0765	CrCrCtD
Menadione—CYP2A6—Amobarbital—epilepsy syndrome	0.0243	0.0672	CbGbCtD
Menadione—CYP2E1—Trimethadione—epilepsy syndrome	0.0212	0.0585	CbGbCtD
Menadione—CYP2E1—Felbamate—epilepsy syndrome	0.0212	0.0585	CbGbCtD
Menadione—CYP2A6—Propofol—epilepsy syndrome	0.0181	0.0501	CbGbCtD
Menadione—CYP2E1—Clonazepam—epilepsy syndrome	0.018	0.0498	CbGbCtD
Menadione—CYP2A6—Phenobarbital—epilepsy syndrome	0.0173	0.0479	CbGbCtD
Menadione—CYP1A1—Propofol—epilepsy syndrome	0.0155	0.0428	CbGbCtD
Menadione—CYP1A1—Phenobarbital—epilepsy syndrome	0.0148	0.0409	CbGbCtD
Menadione—CYP2E1—Rufinamide—epilepsy syndrome	0.0147	0.0406	CbGbCtD
Menadione—CYP2A6—Valproic Acid—epilepsy syndrome	0.0129	0.0358	CbGbCtD
Menadione—CYP2E1—Propofol—epilepsy syndrome	0.012	0.0331	CbGbCtD
Menadione—CYP2E1—Phenobarbital—epilepsy syndrome	0.0114	0.0316	CbGbCtD
Menadione—CYP2E1—Midazolam—epilepsy syndrome	0.0113	0.0312	CbGbCtD
Menadione—CYP2E1—Diazepam—epilepsy syndrome	0.0108	0.03	CbGbCtD
Menadione—CYP1A2—Carbamazepine—epilepsy syndrome	0.00827	0.0229	CbGbCtD
Menadione—CYP1A2—Primidone—epilepsy syndrome	0.00772	0.0213	CbGbCtD
Menadione—CYP1A2—Propofol—epilepsy syndrome	0.00692	0.0191	CbGbCtD
Menadione—CYP1A2—Phenobarbital—epilepsy syndrome	0.00661	0.0183	CbGbCtD
Menadione—CYP1A2—Diazepam—epilepsy syndrome	0.00627	0.0173	CbGbCtD
Menadione—CYP1A2—Valproic Acid—epilepsy syndrome	0.00494	0.0137	CbGbCtD
Menadione—BGLAP—skull—epilepsy syndrome	0.00416	0.0785	CbGeAlD
Menadione—BGLAP—forelimb—epilepsy syndrome	0.00401	0.0756	CbGeAlD
Menadione—F2—forelimb—epilepsy syndrome	0.00249	0.047	CbGeAlD
Menadione—VKORC1—Bortezomib—Lacosamide—epilepsy syndrome	0.00141	1	CbGdCrCtD
Menadione—MTHFR—ganglion—epilepsy syndrome	0.00135	0.0254	CbGeAlD
Menadione—NQO1—ganglion—epilepsy syndrome	0.00112	0.0212	CbGeAlD
Menadione—Phensuximide—CACNA1G—epilepsy syndrome	0.00107	0.346	CrCbGaD
Menadione—NQO2—hindbrain—epilepsy syndrome	0.00102	0.0192	CbGeAlD
Menadione—VKORC1L1—midbrain—epilepsy syndrome	0.000968	0.0183	CbGeAlD
Menadione—Phensuximide—CACNA1H—epilepsy syndrome	0.000967	0.311	CrCbGaD
Menadione—F9—spinal cord—epilepsy syndrome	0.000958	0.0181	CbGeAlD
Menadione—F7—head—epilepsy syndrome	0.000891	0.0168	CbGeAlD
Menadione—F9—head—epilepsy syndrome	0.000851	0.0161	CbGeAlD
Menadione—F7—nervous system—epilepsy syndrome	0.000845	0.0159	CbGeAlD
Menadione—VKORC1L1—head—epilepsy syndrome	0.00084	0.0158	CbGeAlD
Menadione—GGCX—telencephalon—epilepsy syndrome	0.000815	0.0154	CbGeAlD
Menadione—F7—central nervous system—epilepsy syndrome	0.000813	0.0153	CbGeAlD
Menadione—F9—nervous system—epilepsy syndrome	0.000807	0.0152	CbGeAlD
Menadione—VKORC1L1—nervous system—epilepsy syndrome	0.000796	0.015	CbGeAlD
Menadione—MAOB—ganglion—epilepsy syndrome	0.000794	0.015	CbGeAlD
Menadione—F9—central nervous system—epilepsy syndrome	0.000777	0.0147	CbGeAlD
Menadione—VKORC1L1—central nervous system—epilepsy syndrome	0.000766	0.0145	CbGeAlD
Menadione—VKORC1L1—cerebellum—epilepsy syndrome	0.000749	0.0141	CbGeAlD
Menadione—F7—brain—epilepsy syndrome	0.000646	0.0122	CbGeAlD
Menadione—F9—brain—epilepsy syndrome	0.000617	0.0116	CbGeAlD
Menadione—PROS1—medulla oblongata—epilepsy syndrome	0.000608	0.0115	CbGeAlD
Menadione—VKORC1L1—brain—epilepsy syndrome	0.000608	0.0115	CbGeAlD
Menadione—MAOB—hindbrain—epilepsy syndrome	0.000602	0.0114	CbGeAlD
Menadione—NQO2—brainstem—epilepsy syndrome	0.000583	0.011	CbGeAlD
Menadione—MTHFR—forebrain—epilepsy syndrome	0.000565	0.0107	CbGeAlD
Menadione—PROS1—midbrain—epilepsy syndrome	0.000556	0.0105	CbGeAlD
Menadione—PROS1—spinal cord—epilepsy syndrome	0.000543	0.0102	CbGeAlD
Menadione—BGLAP—head—epilepsy syndrome	0.00052	0.00981	CbGeAlD
Menadione—MTHFR—telencephalon—epilepsy syndrome	0.000519	0.0098	CbGeAlD
Menadione—NQO2—telencephalon—epilepsy syndrome	0.000517	0.00976	CbGeAlD
Menadione—GGCX—head—epilepsy syndrome	0.000508	0.00958	CbGeAlD
Menadione—PROS1—head—epilepsy syndrome	0.000482	0.0091	CbGeAlD
Menadione—GGCX—nervous system—epilepsy syndrome	0.000481	0.00908	CbGeAlD
Menadione—NQO1—forebrain—epilepsy syndrome	0.000471	0.00889	CbGeAlD
Menadione—GGCX—central nervous system—epilepsy syndrome	0.000463	0.00874	CbGeAlD
Menadione—PROS1—nervous system—epilepsy syndrome	0.000457	0.00863	CbGeAlD
Menadione—F10—head—epilepsy syndrome	0.000454	0.00856	CbGeAlD
Menadione—GGCX—cerebellum—epilepsy syndrome	0.000453	0.00855	CbGeAlD
Menadione—PROS1—central nervous system—epilepsy syndrome	0.00044	0.0083	CbGeAlD
Menadione—VKORC1—head—epilepsy syndrome	0.000435	0.00821	CbGeAlD
Menadione—NQO1—telencephalon—epilepsy syndrome	0.000433	0.00817	CbGeAlD
Menadione—PROS1—cerebellum—epilepsy syndrome	0.00043	0.00812	CbGeAlD
Menadione—VKORC1—nervous system—epilepsy syndrome	0.000412	0.00778	CbGeAlD
Menadione—NQO2—medulla oblongata—epilepsy syndrome	0.000406	0.00767	CbGeAlD
Menadione—VKORC1—central nervous system—epilepsy syndrome	0.000397	0.00749	CbGeAlD
Menadione—VKORC1—cerebellum—epilepsy syndrome	0.000388	0.00732	CbGeAlD
Menadione—NQO2—midbrain—epilepsy syndrome	0.000371	0.00701	CbGeAlD
Menadione—GGCX—brain—epilepsy syndrome	0.000368	0.00694	CbGeAlD
Menadione—Thalidomide—TNF—epilepsy syndrome	0.000367	0.118	CrCbGaD
Menadione—F2—spinal cord—epilepsy syndrome	0.000364	0.00686	CbGeAlD
Menadione—NQO2—spinal cord—epilepsy syndrome	0.000362	0.00684	CbGeAlD
Menadione—PROS1—brain—epilepsy syndrome	0.000349	0.00659	CbGeAlD
Menadione—MAOB—brainstem—epilepsy syndrome	0.000345	0.00651	CbGeAlD
Menadione—NQO1—medulla oblongata—epilepsy syndrome	0.00034	0.00642	CbGeAlD
Menadione—MAOB—forebrain—epilepsy syndrome	0.000333	0.00628	CbGeAlD
Menadione—MTHFR—head—epilepsy syndrome	0.000323	0.0061	CbGeAlD
Menadione—F2—head—epilepsy syndrome	0.000323	0.0061	CbGeAlD
Menadione—NQO2—head—epilepsy syndrome	0.000322	0.00608	CbGeAlD
Menadione—VKORC1—brain—epilepsy syndrome	0.000315	0.00595	CbGeAlD
Menadione—NQO1—midbrain—epilepsy syndrome	0.000311	0.00587	CbGeAlD
Menadione—F2—nervous system—epilepsy syndrome	0.000307	0.00578	CbGeAlD
Menadione—MTHFR—nervous system—epilepsy syndrome	0.000307	0.00578	CbGeAlD
Menadione—MAOB—telencephalon—epilepsy syndrome	0.000306	0.00578	CbGeAlD
Menadione—NQO2—nervous system—epilepsy syndrome	0.000305	0.00576	CbGeAlD
Menadione—NQO1—spinal cord—epilepsy syndrome	0.000303	0.00572	CbGeAlD
Menadione—MTHFR—central nervous system—epilepsy syndrome	0.000295	0.00557	CbGeAlD
Menadione—F2—central nervous system—epilepsy syndrome	0.000295	0.00557	CbGeAlD
Menadione—NQO2—central nervous system—epilepsy syndrome	0.000294	0.00555	CbGeAlD
Menadione—MTHFR—cerebellum—epilepsy syndrome	0.000288	0.00544	CbGeAlD
Menadione—NQO2—cerebellum—epilepsy syndrome	0.000287	0.00542	CbGeAlD
Menadione—Thalidomide—CYP2C19—epilepsy syndrome	0.00028	0.0902	CrCbGaD
Menadione—NQO1—head—epilepsy syndrome	0.00027	0.00509	CbGeAlD
Menadione—NQO1—nervous system—epilepsy syndrome	0.000256	0.00482	CbGeAlD
Menadione—NQO1—central nervous system—epilepsy syndrome	0.000246	0.00464	CbGeAlD
Menadione—Phensuximide—CYP2C19—epilepsy syndrome	0.000242	0.0779	CrCbGaD
Menadione—NQO1—cerebellum—epilepsy syndrome	0.000241	0.00454	CbGeAlD
Menadione—MAOB—medulla oblongata—epilepsy syndrome	0.000241	0.00454	CbGeAlD
Menadione—F2—brain—epilepsy syndrome	0.000234	0.00442	CbGeAlD
Menadione—MTHFR—brain—epilepsy syndrome	0.000234	0.00442	CbGeAlD
Menadione—NQO2—brain—epilepsy syndrome	0.000233	0.0044	CbGeAlD
Menadione—CYP2A6—cerebellum—epilepsy syndrome	0.00023	0.00435	CbGeAlD
Menadione—AOX1—cerebellum—epilepsy syndrome	0.000221	0.00417	CbGeAlD
Menadione—MAOB—midbrain—epilepsy syndrome	0.00022	0.00415	CbGeAlD
Menadione—MAOB—spinal cord—epilepsy syndrome	0.000215	0.00405	CbGeAlD
Menadione—CYP2E1—telencephalon—epilepsy syndrome	0.000196	0.0037	CbGeAlD
Menadione—NQO1—brain—epilepsy syndrome	0.000195	0.00369	CbGeAlD
Menadione—MAOB—head—epilepsy syndrome	0.000191	0.0036	CbGeAlD
Menadione—CYP2A6—brain—epilepsy syndrome	0.000187	0.00353	CbGeAlD
Menadione—MAOB—nervous system—epilepsy syndrome	0.000181	0.00341	CbGeAlD
Menadione—AOX1—brain—epilepsy syndrome	0.000179	0.00338	CbGeAlD
Menadione—Thalidomide—PTGS2—epilepsy syndrome	0.000174	0.0562	CrCbGaD
Menadione—MAOB—central nervous system—epilepsy syndrome	0.000174	0.00328	CbGeAlD
Menadione—MAOB—cerebellum—epilepsy syndrome	0.00017	0.00321	CbGeAlD
Menadione—CYP2E1—medulla oblongata—epilepsy syndrome	0.000154	0.00291	CbGeAlD
Menadione—MAOB—brain—epilepsy syndrome	0.000138	0.00261	CbGeAlD
Menadione—CYP2E1—spinal cord—epilepsy syndrome	0.000137	0.00259	CbGeAlD
Menadione—CYP1A1—head—epilepsy syndrome	0.000134	0.00253	CbGeAlD
Menadione—CYP1A1—nervous system—epilepsy syndrome	0.000127	0.00239	CbGeAlD
Menadione—CYP1A1—central nervous system—epilepsy syndrome	0.000122	0.00231	CbGeAlD
Menadione—CYP2E1—head—epilepsy syndrome	0.000122	0.0023	CbGeAlD
Menadione—CYP2E1—nervous system—epilepsy syndrome	0.000116	0.00218	CbGeAlD
Menadione—CYP2E1—central nervous system—epilepsy syndrome	0.000111	0.0021	CbGeAlD
Menadione—CYP2E1—cerebellum—epilepsy syndrome	0.000109	0.00206	CbGeAlD
Menadione—CYP1A1—brain—epilepsy syndrome	9.7e-05	0.00183	CbGeAlD
Menadione—CYP2E1—brain—epilepsy syndrome	8.85e-05	0.00167	CbGeAlD
Menadione—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	4.8e-06	4.55e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	4.8e-06	4.55e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PNPO—epilepsy syndrome	4.8e-06	4.55e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GAMT—epilepsy syndrome	4.8e-06	4.55e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—ABCB1—epilepsy syndrome	4.79e-06	4.54e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—AGT—epilepsy syndrome	4.79e-06	4.54e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ALDH7A1—epilepsy syndrome	4.78e-06	4.53e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CACNA1A—epilepsy syndrome	4.78e-06	4.53e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—AGT—epilepsy syndrome	4.73e-06	4.48e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—NT5E—epilepsy syndrome	4.72e-06	4.48e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ALAD—epilepsy syndrome	4.72e-06	4.48e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—APOE—epilepsy syndrome	4.69e-06	4.44e-05	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.69e-06	4.44e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ST3GAL3—epilepsy syndrome	4.68e-06	4.43e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TSC1—epilepsy syndrome	4.67e-06	4.43e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PTK2B—epilepsy syndrome	4.67e-06	4.43e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—APOE—epilepsy syndrome	4.63e-06	4.39e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—AGT—epilepsy syndrome	4.62e-06	4.38e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—AGT—epilepsy syndrome	4.61e-06	4.36e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CHRM3—epilepsy syndrome	4.58e-06	4.34e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—KCNJ11—epilepsy syndrome	4.58e-06	4.34e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ADSL—epilepsy syndrome	4.58e-06	4.34e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NTRK2—epilepsy syndrome	4.55e-06	4.31e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CCR2—epilepsy syndrome	4.55e-06	4.31e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SST—epilepsy syndrome	4.55e-06	4.31e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—APOE—epilepsy syndrome	4.53e-06	4.29e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—DUSP6—epilepsy syndrome	4.51e-06	4.27e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CACNA1A—epilepsy syndrome	4.51e-06	4.27e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ALDH7A1—epilepsy syndrome	4.51e-06	4.27e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—GLUL—epilepsy syndrome	4.49e-06	4.26e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—QDPR—epilepsy syndrome	4.46e-06	4.23e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CA4—epilepsy syndrome	4.46e-06	4.23e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—GPX1—epilepsy syndrome	4.45e-06	4.22e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.45e-06	4.22e-05	CbGpPWpGaD
Menadione—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	4.44e-06	4.21e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PLAT—epilepsy syndrome	4.43e-06	4.2e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CACNA1D—epilepsy syndrome	4.41e-06	4.18e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ST3GAL3—epilepsy syndrome	4.41e-06	4.18e-05	CbGpPWpGaD
Menadione—F10—Hemostasis—AKT1—epilepsy syndrome	4.4e-06	4.17e-05	CbGpPWpGaD
Menadione—F2—Hemostasis—SRC—epilepsy syndrome	4.36e-06	4.13e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ADSL—epilepsy syndrome	4.32e-06	4.09e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—AGT—epilepsy syndrome	4.29e-06	4.07e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.28e-06	4.05e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CXCL12—epilepsy syndrome	4.28e-06	4.05e-05	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—POMC—epilepsy syndrome	4.27e-06	4.05e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.26e-06	4.03e-05	CbGpPWpGaD
Menadione—F2—Hemostasis—VEGFA—epilepsy syndrome	4.24e-06	4.02e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.24e-06	4.02e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—GLUL—epilepsy syndrome	4.24e-06	4.02e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—APOE—epilepsy syndrome	4.21e-06	3.99e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—FGF2—epilepsy syndrome	4.2e-06	3.98e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—JUNB—epilepsy syndrome	4.2e-06	3.98e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CNR1—epilepsy syndrome	4.2e-06	3.98e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—COX3—epilepsy syndrome	4.19e-06	3.97e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PLCB1—epilepsy syndrome	4.18e-06	3.96e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CACNA1D—epilepsy syndrome	4.16e-06	3.94e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—TXNRD1—epilepsy syndrome	4.13e-06	3.91e-05	CbGpPWpGaD
Menadione—AOX1—Disease—FGF2—epilepsy syndrome	4.1e-06	3.89e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HTR7—epilepsy syndrome	4.09e-06	3.88e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—POMC—epilepsy syndrome	4.03e-06	3.82e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—AQP1—epilepsy syndrome	4.01e-06	3.8e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—POMC—epilepsy syndrome	3.98e-06	3.77e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HBEGF—epilepsy syndrome	3.97e-06	3.77e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	3.97e-06	3.77e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	3.97e-06	3.77e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PFKL—epilepsy syndrome	3.97e-06	3.77e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	3.97e-06	3.77e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	3.97e-06	3.77e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—AGT—epilepsy syndrome	3.9e-06	3.7e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AKT3—epilepsy syndrome	3.9e-06	3.7e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—TXNRD1—epilepsy syndrome	3.89e-06	3.69e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—POMC—epilepsy syndrome	3.89e-06	3.68e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.88e-06	3.68e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—POMC—epilepsy syndrome	3.88e-06	3.67e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.86e-06	3.66e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—MTOR—epilepsy syndrome	3.83e-06	3.63e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—APOE—epilepsy syndrome	3.82e-06	3.62e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ADAM10—epilepsy syndrome	3.81e-06	3.61e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—CCL2—epilepsy syndrome	3.79e-06	3.59e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—PTGS2—epilepsy syndrome	3.79e-06	3.59e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—AQP1—epilepsy syndrome	3.78e-06	3.58e-05	CbGpPWpGaD
Menadione—AOX1—Disease—MTOR—epilepsy syndrome	3.74e-06	3.54e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ABCG2—epilepsy syndrome	3.74e-06	3.54e-05	CbGpPWpGaD
Menadione—AOX1—Disease—PTGS2—epilepsy syndrome	3.7e-06	3.51e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—ALB—epilepsy syndrome	3.67e-06	3.48e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CYP2C19—epilepsy syndrome	3.64e-06	3.45e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NEU1—epilepsy syndrome	3.63e-06	3.44e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—UPB1—epilepsy syndrome	3.63e-06	3.44e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ATIC—epilepsy syndrome	3.63e-06	3.44e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—ALB—epilepsy syndrome	3.63e-06	3.44e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.63e-06	3.44e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CHRM3—epilepsy syndrome	3.62e-06	3.43e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—KCNJ11—epilepsy syndrome	3.62e-06	3.43e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	3.62e-06	3.43e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—POMC—epilepsy syndrome	3.61e-06	3.42e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—S100B—epilepsy syndrome	3.6e-06	3.42e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SOCS3—epilepsy syndrome	3.57e-06	3.38e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CDC42—epilepsy syndrome	3.56e-06	3.37e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—ALB—epilepsy syndrome	3.54e-06	3.36e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	3.5e-06	3.32e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AVP—epilepsy syndrome	3.45e-06	3.27e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	3.42e-06	3.24e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	3.42e-06	3.24e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GBE1—epilepsy syndrome	3.38e-06	3.2e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	3.38e-06	3.2e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.3e-06	3.13e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—ALB—epilepsy syndrome	3.29e-06	3.12e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—POMC—epilepsy syndrome	3.28e-06	3.11e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	3.27e-06	3.1e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HES1—epilepsy syndrome	3.26e-06	3.09e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—PTGS2—epilepsy syndrome	3.21e-06	3.05e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.18e-06	3.01e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	3.18e-06	3.01e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PTGS2—epilepsy syndrome	3.17e-06	3.01e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—FYN—epilepsy syndrome	3.17e-06	3e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—H2AFX—epilepsy syndrome	3.16e-06	2.99e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MEF2C—epilepsy syndrome	3.15e-06	2.99e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.12e-06	2.95e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	3.11e-06	2.95e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—PTGS2—epilepsy syndrome	3.1e-06	2.94e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—BCHE—epilepsy syndrome	3.1e-06	2.93e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	3.09e-06	2.93e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—SRC—epilepsy syndrome	3.07e-06	2.91e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.05e-06	2.89e-05	CbGpPWpGaD
Menadione—PROS1—Immune System—AKT1—epilepsy syndrome	3.03e-06	2.87e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NGF—epilepsy syndrome	3.01e-06	2.85e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NT5E—epilepsy syndrome	3.01e-06	2.85e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ALAD—epilepsy syndrome	3.01e-06	2.85e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—ALB—epilepsy syndrome	2.99e-06	2.84e-05	CbGpPWpGaD
Menadione—AOX1—Disease—SRC—epilepsy syndrome	2.99e-06	2.84e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	2.95e-06	2.8e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	2.95e-06	2.8e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CCR5—epilepsy syndrome	2.93e-06	2.78e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	2.92e-06	2.77e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—TH—epilepsy syndrome	2.91e-06	2.76e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—PTGS2—epilepsy syndrome	2.88e-06	2.73e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	2.88e-06	2.73e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	2.87e-06	2.72e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	2.87e-06	2.72e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HTR2A—epilepsy syndrome	2.87e-06	2.72e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	2.86e-06	2.71e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	2.81e-06	2.66e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	2.78e-06	2.64e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ADSL—epilepsy syndrome	2.75e-06	2.61e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TSC2—epilepsy syndrome	2.72e-06	2.58e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AGT—epilepsy syndrome	2.72e-06	2.58e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	2.71e-06	2.57e-05	CbGpPWpGaD
Menadione—F2—Hemostasis—AKT1—epilepsy syndrome	2.71e-06	2.57e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GLUL—epilepsy syndrome	2.7e-06	2.56e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	2.7e-06	2.56e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.68e-06	2.54e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—APOE—epilepsy syndrome	2.67e-06	2.53e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	2.65e-06	2.51e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—PTGS2—epilepsy syndrome	2.62e-06	2.48e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—KDR—epilepsy syndrome	2.61e-06	2.48e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	2.58e-06	2.45e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PRKCB—epilepsy syndrome	2.51e-06	2.38e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IL6ST—epilepsy syndrome	2.5e-06	2.37e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	2.48e-06	2.35e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	2.46e-06	2.33e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—BCHE—epilepsy syndrome	2.45e-06	2.32e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.44e-06	2.31e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	2.43e-06	2.31e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	2.43e-06	2.3e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AQP1—epilepsy syndrome	2.41e-06	2.28e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CAT—epilepsy syndrome	2.4e-06	2.27e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	2.33e-06	2.21e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	2.33e-06	2.21e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	2.32e-06	2.2e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.31e-06	2.19e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	2.31e-06	2.19e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—BCHE—epilepsy syndrome	2.31e-06	2.19e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—TH—epilepsy syndrome	2.3e-06	2.18e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—POMC—epilepsy syndrome	2.29e-06	2.17e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CCL2—epilepsy syndrome	2.24e-06	2.12e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	2.2e-06	2.09e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.18e-06	2.06e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.18e-06	2.06e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	2.18e-06	2.06e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—TH—epilepsy syndrome	2.17e-06	2.06e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—GPX1—epilepsy syndrome	2.17e-06	2.05e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.14e-06	2.02e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.03e-06	1.92e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—FGF2—epilepsy syndrome	2.03e-06	1.92e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.99e-06	1.88e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.92e-06	1.82e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—AKT1—epilepsy syndrome	1.91e-06	1.81e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—AGT—epilepsy syndrome	1.9e-06	1.8e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.89e-06	1.8e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—RELA—epilepsy syndrome	1.88e-06	1.78e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—APOE—epilepsy syndrome	1.86e-06	1.77e-05	CbGpPWpGaD
Menadione—AOX1—Disease—AKT1—epilepsy syndrome	1.86e-06	1.76e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MTOR—epilepsy syndrome	1.84e-06	1.75e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.84e-06	1.75e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	1.81e-06	1.72e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CAT—epilepsy syndrome	1.79e-06	1.69e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.78e-06	1.68e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	1.74e-06	1.65e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.73e-06	1.64e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.72e-06	1.63e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.71e-06	1.62e-05	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.71e-06	1.62e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.71e-06	1.62e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CASP3—epilepsy syndrome	1.7e-06	1.61e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—JUN—epilepsy syndrome	1.65e-06	1.56e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.62e-06	1.53e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—AKT1—epilepsy syndrome	1.62e-06	1.53e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MMP9—epilepsy syndrome	1.6e-06	1.52e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.6e-06	1.52e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—AKT1—epilepsy syndrome	1.6e-06	1.51e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—AKT1—epilepsy syndrome	1.56e-06	1.48e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.56e-06	1.47e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—AKT1—epilepsy syndrome	1.55e-06	1.47e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.55e-06	1.47e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.5e-06	1.42e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SRC—epilepsy syndrome	1.48e-06	1.4e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.48e-06	1.4e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.47e-06	1.39e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.47e-06	1.39e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ALB—epilepsy syndrome	1.46e-06	1.38e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—AKT1—epilepsy syndrome	1.45e-06	1.37e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—VEGFA—epilepsy syndrome	1.44e-06	1.36e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.42e-06	1.34e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.4e-06	1.33e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.39e-06	1.32e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—APOE—epilepsy syndrome	1.39e-06	1.32e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—TH—epilepsy syndrome	1.38e-06	1.31e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.36e-06	1.29e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—AKT1—epilepsy syndrome	1.32e-06	1.25e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	1.28e-06	1.21e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—POMC—epilepsy syndrome	1.26e-06	1.2e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—POMC—epilepsy syndrome	1.19e-06	1.13e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.15e-06	1.09e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.15e-06	1.09e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.14e-06	1.08e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.11e-06	1.05e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ALB—epilepsy syndrome	1.09e-06	1.03e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.03e-06	9.76e-06	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	1.01e-06	9.56e-06	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	9.51e-07	9.01e-06	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AKT1—epilepsy syndrome	9.18e-07	8.7e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AGT—epilepsy syndrome	9.03e-07	8.56e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—APOE—epilepsy syndrome	8.85e-07	8.39e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—POMC—epilepsy syndrome	7.6e-07	7.2e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ALB—epilepsy syndrome	6.93e-07	6.57e-06	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—AKT1—epilepsy syndrome	6.41e-07	6.08e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	6.06e-07	5.75e-06	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—AKT1—epilepsy syndrome	5.07e-07	4.8e-06	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—AKT1—epilepsy syndrome	4.78e-07	4.53e-06	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AKT1—epilepsy syndrome	3.05e-07	2.89e-06	CbGpPWpGaD
